Eight healthy babies born after IVF using DNA from three people | Science

Doctors in the United Kingdom have announced the birth of eight healthy babies after carrying out a revolutionary procedure that creates IVF embryos with DNA of three people to prevent children from inheriting incurable genetic disorders.
Mothers were all at high risk of transmitting potentially fatal diseases to their babies due to mutations in their mitochondria, the tiny structures that are seated inside the cells and provide the power they need to function.
Births and children’s health has long been expected by doctors around the world after the United Kingdom has changed the law to allow the procedure in 2015. The fertility regulator granted the first license in 2017 at a fertility clinic at Newcastle University where doctors have the technique.
The four boys and four girls, including a set of identical twins, were born from seven women and have no signs of mitochondrial diseases that they were likely to inherit. Another pregnancy is underway.
Professor Doug Turnbull, who was part of the team that spent more than two decades developing the procedure, said healthy births were reassuring for researchers and affected families. “You inevitably think it’s great for patients and it is relief,” he said.
Professor Mary Herbert, another senior member of the team, would have eight healthy babies of the procedure “Gratifying for all of us”.
The vast majority of 20,000 genes in a human are curled up in the nucleus of almost all cells in the body. But the liquid surrounding the nucleus contains hundreds to thousands of mitochondria which carry their own set of 37 genes. Mutations of these genes can completely alter or deactivate mitochondria with catastrophic effects.
People inherit all their mitochondria in their biological mother. Murations in the tiny battery structures can affect all the children of a woman.
The first symptoms of mitochondrial disease tend to appear in early childhood while organs swallowed with energy such as brain, heart and muscles begin to fail. Many affected children have development delays, require wheelchairs and die young. About one in 5,000 newborn is affected.
The treatment of a mitochondrial donation, or TMD, aims to prevent children from inheriting mutated mitochondria. The procedure consists in fertilizing the mother’s egg with the father’s sperm, then transferring the genetic material of the nucleus to a fertilized healthy donor who had her own nucleus removed. This creates a fertilized egg with a full set of parents’ chromosomes, but healthy mitochondria of the donor. The egg is then located in the uterus to establish a pregnancy.
The first eight babies born from the procedure are described in two articles by the New England Journal of Medicine. Every eight was in good health at birth. A child has developed a urinary tract infection that has been treated, and another has developed muscle tremors that have resolved by themselves. A third child has developed high blood fat and disruption in their heart rate, which was also treated. It is believed that the condition is linked to a medical problem that the mother had during pregnancy.
Genetic tests have shown that babies had no low levels of mutant mitochondria, some mother reported during the procedure. Although the levels are considered too low to cause a disease, it suggests that the procedure could still be improved.
“All children are well and they continue to respect their development stages,” said Bobby McFarland, director of highly specialized NHS service for rare mitochondria of the Newcastle Hospital NHS Foundation Trust. Five of children are less than a year old, two are between one and two and the other child is older.
The mother of one of the girls said: “As parents, everything we always wanted was to give our child a healthy beginning of life. After years of uncertainty, this treatment gave us hope – and then that gave us our baby … We are overwhelmed with gratitude. Science gave us a chance.”
Some women who carry genetic disorders produce eggs with different levels of defective mitochondria. For them, a technique called pre -implantation genetic test (PGT) can be used to select eggs for IVF which are very small likely to transmit a disease. Other women do not have this choice because all their eggs have high levels of changes.
The Newcastle team said that eight out of 22 (36%) of women got pregnant after the MDT and 16 of the 39 (41%) of women fell pregnant after the PGT. We do not know why the rates differ, but some mitochondrial mutations can have training effects on fertility.
Writing in an editorial that accompanies him, Robin Lovell-Badge, a leader of the Senior Group at the Francis Crick Institute in London, said that the long road so had “undoubtedly frustrating for women at risk of having children with DNA disease”, but praised the prudent approach to scientists.


